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ABSTRACT 
CSR is a challenging disease to understand and treat, since its 
pathogenesis remains elusive and multifactorial. CSR is an idiopathic 
disorder characterised by a localised serous detachment of sensory 
retina at the macula secondary to leakage from the choriocapillaries 
through one or more hyperpermeable RPE sites. In Ayurvedic literature, 
all the conditions which cause impairment of vision are included under 
Timiraroga. The present case CSCR, can be included under 
Sannipathikatimira. The treatment procedure Vamana is contraindicated 
in Timira but CSR is a disease in which excessive accumulation of serous 
fluid. So, it can be considered as Ekamgajasopha. The first line of 
treatment of Sopha is Apatarpana. Vamana is one of the Apatarpana 
procedures. So, Vamana can be incorporated in CSR.  
Management of CSR usually involves the use of laser photocoagulation, 
photodynamic therapy with verteporfin and anti VEGF agents in case of 
choroidal neovascularization related to CSR. As per Ayurvedic classics 
this condition can be included under Timiraroga. This article describes a 
case report of 47 years old male patient presented with CSR. In present 
study, Sadyovamana is found very effective to improve his visual acuity. 
OCT studies showed almost total absorption of subretinal fluid after 
treatment. 
 
INTRODUCTION 
Central serous chorioretinopathy (CSCR) is 
one of the several chorio retinal disorders 
characterised by idiopathic serous detachment of 
the neuro sensory and/or RPE at the posterior pole 
of the fundus with consequent accumulation of 
fluid.[1] CSR mostly affects healthy males between 
25 to 55 years of age. The disorder is most common 
in males, compared to females with the ratio 3:1 to 
6:1 in various studies[2]. Other reported risk factors 
include hyperopia or emmetropia, stress, Type A 
personality, hypertension and chronic use of 
corticosteroid or psychotropic medications, 
pregnancy and oral contraceptives[1]. 
The most common presenting symptoms of 
CSR are decreased and distorted vision. The visual 
acuity is usually occurred to 6/9 to 6/18. Other 
symptoms includes metamorphosia, micropsia, 
altered colour vision and a central dimness in vision 
that may have a grey or purple cast[1]. Acute classic 
CSR usually present as a solitary, localised 
neurosensory detachment at the posterior pole. 
Serous retinal pigment epithelial detachment seen 
as smooth, circumscribed, orange coloured 
elevation with darker rims may be found in 
association with classic CSR.[1] 
Chronic CSCR presents as relatively broad 
and shallow areas of neuro sensory detachment 
with thinning or even cystoid changes within the 
retina. These are often accompanied by RPE 
alterations including atrophy or loss of 
pigmentation, focal areas of hyperpigmentation or 
RPE hyperplasia to the point of formation of bony 
spicules. In addition, tracks of fluid descending 
inferiorly up to the equator may also be seen[1]. The 
diagnosis is performed by dilated fundus exam and 
image of retina and the choroid with OCT, Fundus 
Case Study 
*Address for correspondence 
Dr. Sreekumar.K 
Associate Professor, 
Dept. of Shalakyatantra, 
Govt. Ayurveda College, 
Thiruvananthapuram, Kerala. 
Email: 
drsreekumarmsayu@yahoo.co.in  
AYUSHDHARA, 2020;7(2):2681-2684 
 AYUSHDHARA | March - April 2020 | Vol 7 | Issue 2  2682 
flurescein angiography and Indocyanine Green 
(ICG) angiography, Fundus auto fluorescence. 
Several theories have been proposed to 
explain the pathogenesis of CSCR. A break in the 
integrity of RPE causing the subretinal 
accumulation of fluid is CSCR. Chorodial vascular 
hyperpermeability, this in turn increases the tissue 
hydrostatic pressure in the choroid causing PED, 
disruption of RPE barrier and abnormal egress of 
fluid under the neuro sensory retina leading to 
CSCR.  
Current treatment modalities for CSCR 
generally target the RPE, choroid or both. They aim 
to improve the ability of the RPE to remove the 
subretinal fluid, to diminish leakage from the 
choroid vessels, or to decrease fluid flux across the 
RPE barrier[3]. Management usually involves either 
waiting for spontaneous resolution, which 
commonly occurs within 3 months of onset or the 
use of focal laser photocoagulation, photodynamic 
therapy with verteporfin and anti-vascular 
endothelical growth factor (anti-VEGF) agents in 
cases of choroidal neovascularisation related to 
CSCR[4]. In Ayurvedic literature, all the conditions 
which cause impairment of vision are included 
under Timiraroga[5]. The present case CSR, can be 
included under Sannipathikatimira. The treatment 
procedure Vamana is contraindicated in Timira[6]. 
But CSR is a disease in which excess accumulation 
of serous fluid. So, it can be considered as 
Ekamgajasopha. The first line of treatment of Sopha 
is Apatarpana[7]. Vamana is one of the Apatarpana 
procedures. So, Vamana can be incorporated in CSR.  
Aims and objectives 
To study the efficacy of Sadyovamana in CSCR. 
Materials and Methods 
A 47 years old male patient of CSR was 
selected from OPD, Department of Shalakyatantra 
government Ayurveda College, 
Thiruvananthapuram. 
Case Report 
A 47-year-old male patient approached the 
OPD presented with diminution and blurring of 
vision associated with central dimness of both eyes 
especially right eye for two weeks. He is a carpenter 
he can't equalize the lines drawn on two wood 
pieces. So he consulted in Government Ayurveda 
College, Thiruvananthapuram on 16 / 01 /2020 and 
undergone fundus examination and suspected CSR. 
So he was referred for OCT and thus confirmed CSR. 
 
Chief complaints and associated symptoms 
 Diminution and blurring of vision associated 
with central dimness of vision in both eyes 
especially right eye for the last 2 weeks 
Personal History 
 Bowel - Regular 
 Appetite - Moderate 
 Micturition - Normal 
 Sleep - Good 
History of previous illness 
History of using spectacles since 3yrs. 
Patient had a chronic history of using inhalers for 
dyspnea. 
Family history 
Nothing relevant 
Investigations 
Visual Acuity 
RE 
(Unaided) 
With 
Glass 
LE 
(Unaided) 
With 
Glass 
CF 3m 6/9p 5/60p 6/36p 
OCT - Show serous detachment of neurosensory 
retina with accumulation of subretinal fluid. 
Diagnosis 
 CSCR (Sannipathika Timira) 
Line of Management 
 Purva karma- Agnideepana 
 Sadyasneha- gruel with ghee for 3 days 
 4th day- Abhyanga and Ushnambusnana, at night 
Utklesakara food with milk and Uzhunnuvada 
 5th day- Virechana with Avipattichoorna 20gm 
 6th day- Sadyovamana with Yashtimadhu 
kashaya and saline water. 
Observation and Result 
 After Vamana, the patient got significant 
improvement in visual acuity. OCT shows almost 
total absorption of sub retinal fluid. He was advised 
to take Dasamula Kashaya 90ml bd, 
Hingutrigunataila 5ml with Kashaya at night. 
Visual 
acuity 
UCVA BCVA 
RE LE RE LE 
BT CF - 3m 5/60p 6/9P 6/36P 
AT 6/18 6/36 6/9P 6/24P 
Follow up 6/18 6/24p 6/9P 6/24P 
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DISCUSSION 
In Ayurvedic literature, all the conditions 
which cause impairment of vision are included 
under Timiraroga. The present case CSR, can be 
included under Sannipathikatimira. During Vamana, 
inspiratory thoracic and abdominal wall muscles 
contract –raised intra thoracic and intra-abdominal 
pressure. Increasing intra thoracic pressure against 
a closed glottis diminishes the venous return to the 
heart, decreasing stroke volume and subsequently 
increasing the venous system pressure. As the 
sudden rise in intra ocular venous pressure occurs, 
a spontaneous rupture of retinal capillaries ensues. 
This may be the reason for general contraindication 
of Vamana in Drishti rogas. But as per the specific 
pathophysiology of CSCR concerned, this sudden 
OCT before Treatment 
OCT After Treatment 
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change in the venous pressure may enhance the 
immediate absorption of SRF. 
CSR is a disease in which excess 
accumulation of serous retinal fluid under 
neurosensory retina. So it can be considered as 
Ekangajasopha. The cardinal feature of Sopha is 
Utseda, meaning elevation from normal site, which 
is the cardinal feature of CSCR as evident from the 
OCT findings. The first line treatment of Sopha is 
Apatarpana[7] and Vamana is one of the Apatarpana 
procedures. In Sopha Samprapti, Rasavaha 
srotodushti is the key factor causing the localised 
collection of fluid, here in case of CSCR, in the retina. 
Treatment of Rasavaha srotodushti is also 
Vamana[8]. From these classical references we adopt 
Vamana in the treatment of CSR. 
Vamana karma is the specific therapy for 
Kaphaja disorders[6]. Vamana drugs possessing the 
properties like Ushna, Teekshna, Sukshma, Vyavayi 
and Vikashigunas reach Hridaya by its own Veerya, 
mobilizing the vitiated Doshas in the Sakha and 
bring them back to Koshta[9]. Hrideya may be heart 
or brain because both are able to carry Dravya all 
over the body in a short duration by using their 
circulatory or nervous system respectively. When 
Vamaka dravyas reaches the stomach they stimulate 
gastric mucosa, stimulated vagus and sympathetic 
nerve that carry signals to the vomiting centre and 
induces emesis. 
Current treatment modalities for CSCR 
generally target the RPE, choroid or both. They aim 
to improve the ability of the RPE to remove the 
subretinal fluid, to diminish leakage from the 
choroid vessels, or to decrease fluid flux across the 
RPE barrier. According to various Ayurvedic 
classics, the ultimate results of Vamana coincide 
with the current treatment modalities in the 
modern science. According to Astangahridaya, 
Samyakshodhana results in to strength of Indriyas 
(sense organs), stability of Dhatus (body tissue), 
improvement of Agni.[10] 
Susruta samhita, mentioned that the person 
undergoing Vamana never develop Malavriddhi in 
Srotasas (accumulation of waste in body channels 
i.e., excessive fluid accumulation), Kaphasrava 
(excessive fluid secretion), Grahani (Mal 
absorption)[11]. By Vamana, the vitiated and 
aggressive Kaphadosha is expelled out of the body, 
leading to cure of disease. i.e., in CSR excessive 
accumulation of fluid is ultimately expelled out. This 
will certainly improve the functions of RPE and 
normal health of RPE and choroid is restored. 
CONCLUSION 
Management of CSR with Sadyovamana has 
a significant role in improving visual acuity and 
absorption of the accumulated serous fluid. 
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